Two researchers describe their experiences with cancer research funding cuts due to the Trump administration’s policies and actions.

The ASPR must update its 2022 list of 86 essential medicines and provide a plan to store and maintain a 6-month supply of APIs for drugs on the updated list, the order states.

Fifty-four percent of Americans surveyed said they drink alcohol — the lowest rate Gallup has recorded in nearly 90 years of tracking.

The mechanism we delineated … can be targeted at multiple levels with existing drugs, potentially improving disease outcomes in this patient population,” said Lorenzo Galluzzi, PhD.

Patient comorbidities, dual-eligibility status, and area-level poverty were the strongest contributing factors to the disparities observed between Black and White patients, researchers found.

Physician attire impacts patients' perceptions of professionalism, trust, and communication, but perceptions are highly context-dependent, research suggests.

These discoveries underscore the huge impact of respiratory viral infections on metastatic cancer resurgence, offering new insights into the connection between infectious diseases and cancer ...

The nationwide shortage of sodium chloride 0.9% intravenous saline has officially ended, according to the FDA.

The FDA has accepted for review the NDA for vepdegestrant to treat ESR1-mutated, ER+, HER2- advanced breast cancer.

US health officials have informed leading medical organizations that they will no longer be invited to participate in developing vaccination recommendations.

Recent news reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and scientific research funding in jeopardy.

The One Big Beautiful Bill Act will have negative impacts on cancer patients, oncologists, and the health care system at large, experts say.